WO2000074716A3 - Ige peptides for allergy immunotherapy - Google Patents
Ige peptides for allergy immunotherapy Download PDFInfo
- Publication number
- WO2000074716A3 WO2000074716A3 PCT/EP2000/005164 EP0005164W WO0074716A3 WO 2000074716 A3 WO2000074716 A3 WO 2000074716A3 EP 0005164 W EP0005164 W EP 0005164W WO 0074716 A3 WO0074716 A3 WO 0074716A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- allergy
- ige
- composition
- treatment
- immune response
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/5555—Muramyl dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU58116/00A AU5811600A (en) | 1999-06-08 | 2000-06-06 | Vaccine |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9913327.4A GB9913327D0 (en) | 1999-06-08 | 1999-06-08 | Vaccine |
GB9913327.4 | 1999-06-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000074716A2 WO2000074716A2 (en) | 2000-12-14 |
WO2000074716A3 true WO2000074716A3 (en) | 2001-07-19 |
Family
ID=10854961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/005164 WO2000074716A2 (en) | 1999-06-08 | 2000-06-06 | Ige peptides for allergy immunotherapy |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5811600A (en) |
GB (1) | GB9913327D0 (en) |
WO (1) | WO2000074716A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6849260B2 (en) | 2000-08-18 | 2005-02-01 | Amgen Inc. | Methods and compositions for treating IgE-related disease using NNT-1 inhibitors |
CN102702359A (en) * | 2004-02-02 | 2012-10-03 | 泰勒公司 | Identification of novel igE epitopes |
EP1930729A1 (en) * | 2006-12-04 | 2008-06-11 | Medizinische Universität Wien | Method for in vivo and in vitro testing for a pharmaceutical drug induced immediate type hypersensitivity reactions |
US9920100B2 (en) | 2015-06-05 | 2018-03-20 | The Chinese University Of Hong Kong | Mimotopes of tropomyosin for use in immunotherapy for shellfish and/or arthropod allergy |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4261973A (en) * | 1976-08-17 | 1981-04-14 | Pharmacia Ab | Allergen-containing substances |
WO1995026365A1 (en) * | 1994-03-28 | 1995-10-05 | United Biomedical, Inc. | Synthetic peptide based immunogens for the treatment of allergy |
WO2000050460A1 (en) * | 1999-02-25 | 2000-08-31 | Smithkline Beecham Biologicals S.A. | Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses |
-
1999
- 1999-06-08 GB GBGB9913327.4A patent/GB9913327D0/en not_active Ceased
-
2000
- 2000-06-06 AU AU58116/00A patent/AU5811600A/en not_active Abandoned
- 2000-06-06 WO PCT/EP2000/005164 patent/WO2000074716A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4261973A (en) * | 1976-08-17 | 1981-04-14 | Pharmacia Ab | Allergen-containing substances |
WO1995026365A1 (en) * | 1994-03-28 | 1995-10-05 | United Biomedical, Inc. | Synthetic peptide based immunogens for the treatment of allergy |
WO2000050460A1 (en) * | 1999-02-25 | 2000-08-31 | Smithkline Beecham Biologicals S.A. | Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses |
Non-Patent Citations (1)
Title |
---|
D.R. STANWORTH ET AL.: "Allergy treatment with a peptide vaccine.", THE LANCER, vol. 336, 24 November 1990 (1990-11-24), LONDON, GB, pages 1279 - 1281, XP002157626 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000074716A2 (en) | 2000-12-14 |
AU5811600A (en) | 2000-12-28 |
GB9913327D0 (en) | 1999-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL125590A (en) | Peptide immunogens, process for their preparation and use thereof as vaccines against allergies | |
NZ281409A (en) | Medicaments for cancer treatment using peptides based on a 9 AA epitiope derived from mage -3 that induces ctls | |
CA2290485A1 (en) | Method for the production of non-immunogenic proteins | |
AU2002347369A8 (en) | Immunotherapeutic methods and systems | |
ATE244891T1 (en) | METHOD FOR SELECTION AND PRODUCTION OF T-CELL PEPTIDES EPITOPES AND VACCINES WITH THESE EPITOPES | |
HUP0301789A2 (en) | Recombinant anti-cd40 antibody and uses thereof | |
NZ508381A (en) | Antibodies, antagonists and agonists of the death domain containing receptor 5 (DR5) | |
DK1098910T3 (en) | Antigen Complex Containing Immune Stimulating Peptide, CD4 and Chemokine Receptor Domain for the Treatment of HIV and Immune Diseases | |
CA2243559A1 (en) | Pharmaceutical composition for immunomodulation | |
AUPN568095A0 (en) | Anti-Galalpha(1,3)Gal antibody binding peptides | |
GEP20022695B (en) | Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof | |
Lingnau et al. | Poly-L-arginine synergizes with oligodeoxynucleotides containing CpG-motifs (CpG-ODN) for enhanced and prolonged immune responses and prevents the CpG-ODN-induced systemic release of pro-inflammatory cytokines | |
McCabe et al. | Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses | |
WO2000075173A3 (en) | Peptide fragments of colostrinin | |
Ahmad et al. | DNA vaccination for prostate cancer, from preclinical to clinical trials-where we stand? | |
ATE524192T1 (en) | PEPTIDE SUITABLE FOR IMMUNE MODULATION | |
WO2000074716A3 (en) | Ige peptides for allergy immunotherapy | |
UA83989C2 (en) | Isolated peptide for promoting anti-tumor immune response, pharmaceutical composition based thereon and use thereof | |
CA2440610A1 (en) | Induction of tumor immunity by variants of folate binding protein | |
WO2000052045A3 (en) | Mage-3 derived immunogenic peptides presented by mhc of class ii and the use thereof | |
Schappert et al. | Soluble MHC class I complexes for targeted immunotherapy | |
AU2003217758A1 (en) | Cytokines and cytokine receptors with reduced immunogenicity | |
WO2002044202A3 (en) | Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof | |
AU4712993A (en) | New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods | |
AU5872594A (en) | Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |